[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "New US vaccine and a missing mutant", "description": "UK\n\nhttps://coronavirus.data.gov.uk/details/cases\n\nCases, + 61,045\nDown 21.2%\n\nHospital admissions, + 8,460\nDown 22.1%\n\nDeaths, + 2,270\nDown 33.5%\n\nVaccine, first dose, 20,089,551\n\nSecond dose, 796,132\n\nhttps://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/963532/COVID-19_vaccine_effectiveness_surveillance_report_February_2021_FINAL.pdf\n\nPfizer in over 80s\n\nN = 11,860 cases in the UK\n\nInfections continue to decrease for four weeks after vaccination and then plateau\n\nLower rate of admission amongst vaccinated, at least 14 days after a single dose\n\nVaccinated individuals who do become symptomatic, protection against death. \n\nPfizer in over 70s\n\nIn context\n\nSIREN (Sarscov2 Immunity and REinfection EvaluatioN), protection against infection, after a single dose of \n\nPfizer, 72%\n\nIsrael that suggested 75% protection against all infections\n\n85% against symptomatic infection after a single dose of Pfizer\n\nP1 variant\n\nhttps://www.bbc.co.uk/news/uk-56234302\n\nSix found in the UK in February\n\nUnidentified person, infected with P1 variant, took a test 12th or 13th February\n\nShould be self-isolating for 10 days\n\nMay or may not have flown into UK\n\nHotel quarantine rule started 15th February\n\nUnited States\n\nTrends\n\nhttps://covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases\n\nHospitalizations\n\nhttps://covid.cdc.gov/covid-data-tracker/#hospitalizations\n\nVaccinations\n\nOne or more doses, 49,772,180 (15%)\nTwo doses, 24,779,920 (7.5%)\n\nAd26.COV2.S\n\nOnly single dose vaccine in use\n\nhttps://www.washingtonpost.com/health/2021/02/28/johnson-and-johnson-vaccine-cdc-recommendation/\n\nCenters for Disease Control and Prevention, approves 3rd vaccine for over 18s\n\nFood and Drug Administration, Saturday, emergency use\n\nStart shipping doses, today\n\n3.9 million doses this week\n\n20 million doses by the end of March\n\nStorage / transport\n\nUp to two years frozen at \u20134\u00b0 F (\u201320\u00b0 C)\n\nUp to three months refrigerated at 36\u201346\u00b0 F (2\u20138\u00b0 C).\n\nPhase 3, n = 45,000 \n\nUS agreed to pay Johnson & Johnson $1 billion for 100 million doses if approved\n\nEU has ordered 200 million doses\n\nCOVAX, 500 million doses\n\nHoped for production, 1 billion doses in 2021\n\nNovember 16, announced 2 dose Phase 3 trial\n\nFebruary, started trial for pregnant women\n\nJanssen\n\nUS efficacy data\n\n85% effective at protecting against severe cases \n\n72% effective in preventing moderate illness \n\n100% effective in preventing hospitalization and death after one month\n\nThree vaccines, tested at different times, different variants, different levels of transmission\n\nSeven deaths in the trial, all in placebo group\n\nSaad Omer, Yale Institute of Global Health\n\nthe more severe the outcome, the more similar the efficacy\n\nChile\n\nhttps://www.emol.com/noticias/Nacional/2021/03/01/1013539/Daza-por-brote-hogar-vacunados.html\n\nOutbreak in elderly care facility\n\n40 tested positive\n\nNo serious illness\n\nThree weeks after Sinovac\n\nHTTPS://WWW.NYTIMES.COM/INTERACTIVE/2020/SCIENCE/CORONAVIRUS-VACCINE-TRACKER.HTML#SINOVAC\n\nCoronaVac\n\nEfficacy, 50 - 90%\n\n2 doses, 2 weeks apart, IM, Refrigerated, Inactivated\n\nYet to publish\n\nIndonesia, 11th January\n\nTurkey, 13th January\n\nBrazil, 17th January\n\nBillion doses per year\n\nIndia\n\nPeople above 60\n\nOver 45 with certain medical conditions\n\nModi accepts vaccine\n\nCzech Republic\n\nWorld\u2019s worst surge in Covid-19 infections\n\nStricter enforced measures\n\nBelgium\n\nhttps://www.theguardian.com/world/2021/mar/01/belgium-considers-u-turn-on-oxford-astrazeneca-covid-vaccine-for-over-55s\n\nGovernment to reset vaccination programme\n\nPeople over 55 could be given Oxford/AstraZeneca\n\nScotland, overall 81% reduction in hospital admissions\n\n(Belgium, Germany, France, Poland, Italy)\n\nHospital admissions, up 44% on last week\n\nVaccinated, 7% (UK 31%)\n\nEU\u2019s 27 member states, 7.26%.\n\nEuropean Commission\n\nhttps://www.theguardian.com/world/live/2021/mar/01/coronavirus-live-news-vaccine-acceptance-rising-in-uk-us-and-france-south-africa-eases-restrictions\n\nPropose EU-wide digital Covid-19 vaccination passport\n\nAllow Europeans to travel more freely over summer\n\ndigital green pass", "link": "https://www.youtube.com/watch?v=0pkkkt-Xb1U", "date_published": "2021-03-01 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Excellent vaccine results, takes time", "description": "BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting\n\nhttps://www.nejm.org/doi/full/10.1056/NEJMoa2101765?query=featured_home\n\nMETHOD\n\nVaccinations, December 20, 2020, to February 1, 2021\n\nMatched to unvaccinated controls in a 1:1 ratio\n\nAccording to demographic and clinical characteristics\n\nN = 596,618 (in each group)\n\nDOCUMENTED INFECTIONS, 10,561 \n\nSymptomatic infections, 5,996 (57%)\n\nRequiring hospitalisation, 369\n\nSevere cases of Covid-19, 229\n\nDeaths, 41\n\nRESULTS\n\nVaccine effectiveness at days 14 through 20 after the first dose\n\nVaccine effectiveness at 7 or more days after the second dose\n\nDocumented infection\n\n46% and 92%\n\nSymptomatic Covid-19\n\n57% and 94% \n\nHospitalization \n\n74% and 87% \n\nLast hospitalisation in the vaccinated group at 32 days\n\nSevere disease\n\n62% and 92% \n\nLast severe case in the vaccinated group at 30 days\n\n\nEffectiveness in preventing death\n\n72% for days 14 through 20 after the first dose \n\nDeaths after 44 days\n\nVaccinated group, 9 \n\nUnvaccinated group, 32 \n\nLast death in the vaccinated group at 30 days\n\nCONCLUSIONS\n\nConsistent with a gradual daily increase in vaccine effectiveness\n\nThis study in a nationwide mass vaccination setting suggests that the BNT162b2 mRNA vaccine is effective for a wide range of Covid-19\u2013related outcomes, a finding consistent with that of the randomized trial.", "link": "https://www.youtube.com/watch?v=sNCrzOl2PfA", "date_published": "2021-02-28 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]